Joseph Turk
Kathleen O'Donnell
Kathleen O’Donnell is the Vice President of Marketing and New Business Development at ReWalk Robotics. Ms. O’Donnell received her Bachelor’s degree in Biomedical/Medical Engineering, Science in Human Cultures from Northwestern University, and her Master’s in Industrial Design from the Rhode Island School of Design.
Prior to joining ReWalk, Kathleen worked at the Wyss Institute for Biologically Inspired Engineering at Harvard University, where she combined her backgrounds in biomedical engineering and design to help lead the development and testing of exo-suits. She began her journey at ReWalk Robotics, acting first as Clinical Trials Manager where she facilitated the successful commercialization of the ReStore Exo-suit. Prior to serving in her current role, she also served as ReWalk Product Manager and then as Director of Product Management.”
David Hexner
David Hexner joined ReWalk in November of 2011 and currently serves as Vice President of Research and Development. David has played an integral role in the development of both the ReWalk Exoskeleton and the ReStore Exo-suit, beginning first in the role of Software and Algorithms Engineer, then that of Program Manager and finally of Director of Research and Development prior to joining the management team in 2021.
Mr. Hexner received his Bachelor’s Degree in Electrical Engineering, as well as his Masters of Business Administration from the Technion-Israel Institute of Technology. Prior to joining ReWalk, David previously worked at Zoran Electronics which used to be a leading player in the semiconductor market which developed and sold chip sets for consumer electronics.
Jeannine Lynch
Jeannine Lynch joins ReWalk Robotics with a focus on completing the building and implementation of ReWalk’s market access and reimbursement programs.
Prior to ReWalk, Ms. Lynch served as Senior Director of Patient Access Services at BioMarin Pharmaceuticals. In addition to her work with BioMarin, Ms. Lynch has worked for industry leaders such as Genentech and Pfizer/Agouron. She has held leadership roles in commercial management, product launches and built customized patient services to address several different rare and ultrarare medical conditions.
Ms. Lynch is a graduate of the University of California Berkeley and holds a Master of Public Health from the University of Michigan. She sits on the Board of Directors for MVP, a non-profit organization to help young people of color prepare, perform, progress, and prosper in their education, leadership and early professional careers.